Yokneam, Israel (Vocus/PRWEB) February 03, 2011
Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based devices for Surgical, Aesthetic, and Ophthalmic applications, reported today on global collaboration with leading physicians and organizations in the treatment of burn scars, traumatic injury scars and other skin abnormalities using their proprietary UltraPulse Fractional CO2 laser technology.
Dr. Rox Anderson, Professor and Dermatologist at Harvard Medical School, a world renowned leader of laser technology for more than two decades, and at the forefront of a global movement bringing new hope and help to burn survivors, recently returned from a two-week medical mission to China and Vietnam where he and his colleagues treated over 100 patients at the Vietnam Vascular Anomalies Center (VAC) and trained local physicians. Lumenis helped to make the treatments and training possible through a donation of an UltraPulse laser system and physician travel arrangements.
“Our initial efforts focused on treating hemangiomas and other skin abnormalities, but with the advent of UltraPulse fractional technology, we quickly realized that there was an opportunity to treat burn victims, especially children,” said Dr. Anderson, “Our Mission at VAC is to offer help and hope to these children. The best way to do this is to enable and train local physicians on the latest techniques so they can offer a service that was not possible in Vietnam, or anywhere else in the world, five years ago. With Lumenis’ technology and support, we are able to achieve this.” This marks the first such international effort for the laser treatment of scars of this magnitude.
Dr. Jill Waibel, a renowned private practice physician and an expert in burn scar treatment in the USA, will present clinical results on burn scars using the UltraPulse fractional CO2 laser at the American Academy of Dermatology (AAD) Annual Meeting taking place in New Orleans beginning February 4th, 2011. One of Dr. Waibel’s patients, Lesia Cartelli, founder of Angel Faces, an organization that provides healing retreats and ongoing support to adolescent girls with severe facial disfigurements, will be present to share her personal experience and clinical improvements first hand.
“Recent medical advancements have enabled the survival of patients with burns covering 80% to 90% of their body. This has created a reconstruction situation that we haven’t seen before,” said Dr. Waibel. “UltraPulse has had a dramatic impact on the treatment of scars because it is the only laser that can reach the depths required to treat deep scars – Lumenis’ UltraPulse is the only hope that these patients have.”
The Armed Forces sector is also a significant benefactor of this novel treatment modality. Lt. Col. Chad Hivnor, M.D., chief of pediatric dermatology at Wilford Hall Medical Center was the first to introduce UltraPulse fractional laser treatment to wounded warriors. “I saw more and more soldiers returning with severe burns and scars and there was no treatment to offer them,” said Lt. Col. Hivnor. “I knew UltraPulse worked well for acne scars, so it made sense that it would help this scarring. We’ve seen a dramatic improvement in pliability and mobility.”
“The success of this treatment can be attributed to the support of the medical community, especially these dermatologists and plastic surgeons who are so passionate about this cause,” said Mr. Robert Mann, Sr. VP and General Manager of Global Aesthetics and Dermatology at Lumenis. “It is our privilege to support them with our UltraPulse fractional technology.”
Lumenis has the most extensive experience in the area of burn scars and traumatic injury scars in the industry. Collaborations for the treatment of burn scars and traumatic injury scars include: Three for Hope Foundation (USA), Katie Piper Foundation (UK), Angel Faces (USA), Missions for Children (Ecuador), Vascular Anomalies Center (Vietnam), Lackland Air Force Base Wounded Warriors and San Diego Naval Hospital Wounded Warriors.
Lumenis is renowned in the Dermatology Community for aesthetic and cosmetic procedures, bringing over forty years of laser research and development across most surgical specialties - this extensive experience provides the foundation for such scientific breakthroughs.
Lumenis, the world's largest medical laser company, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, ophthalmic and aesthetic applications, with more than 800 employees worldwide. Lumenis has nearly 250 patents, over 125 FDA clearances, an installed base of over 80,000 systems and presence in over 100 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from the Latin words meaning "Light of Life" highlighting the light which is the basis of our technologies used to enhance life. For more information about Lumenis and its products, please visit: http://www.lumenis.com
For further information contact:
Director of Corporate Communications
Lumenis® is a registered trademark of Lumenis Ltd.
UltraPulse® is a trademark of Lumenis Ltd.
# # #